Literature DB >> 20045105

Metaphase II human oocyte morphology: contributing factors and effects on fertilization potential and embryo developmental ability in ICSI cycles.

Rita de Cássia S Figueira1, Daniela Paes de Almeida Ferreira Braga, Luciana Semião-Francisco, Camila Madaschi, Assumpto Iaconelli, Edson Borges.   

Abstract

Morphologic abnormalities in the oocyte are relevant for determining its developmental fate and could be related to controlled ovarian stimulation protocols and ovarian response. The contributing factors of oocyte dysmorphism incidence and its effects on fertilization potential and embryo development are the object of discussion in this study. Copyright (c) 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2009        PMID： 20045105     DOI： 10.1016/j.fertnstert.2009.11.039

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  17 in total

1.  Oocyte morphology does not affect post-warming survival rate in an egg-cryobanking donation program.

Authors:  Amanda Souza Setti; Rita de Cássia Savio Figueira; Daniela Paes de Almeida Ferreira Braga; Renata Cristina Ferreira; Assumpto Iaconelli; Edson Borges
Journal:  J Assist Reprod Genet       Date:  2011-12-04       Impact factor: 3.412

2.  The effect of immature oocytes quantity on the rates of oocytes maturity and morphology, fertilization, and embryo development in ICSI cycles.

Authors:  Iman Halvaei; Mohammad Ali Khalili; Mohammad Hossein Razi; Stefania A Nottola
Journal:  J Assist Reprod Genet       Date:  2012-05-30       Impact factor: 3.412

3.  Pregnancy with oocytes characterized by narrow perivitelline space and heterogeneous zona pellucida: is intracytoplasmic sperm injection necessary?

Authors:  Mei Li; Shui-Ying Ma; Hui-Jun Yang; Ke-Liang Wu; Wan-Xia Zhong; Guan-Ling Yu; Zi-Jiang Chen
Journal:  J Assist Reprod Genet       Date:  2014-01-10       Impact factor: 3.412

4.  Ultrastructural and cytogenetic analyses of mature human oocyte dysmorphisms with respect to clinical outcomes.

Authors:  Mário Sousa; Mariana Cunha; Joaquina Silva; Elsa Oliveira; Maria João Pinho; Carolina Almeida; Rosália Sá; José Teixeira da Silva; Cristiano Oliveira; Alberto Barros
Journal:  J Assist Reprod Genet       Date:  2016-05-24       Impact factor: 3.412

5.  The predictive value of high-magnification sperm morphology examination on ICSI outcomes in the presence of oocyte dysmorphisms.

Authors:  Amanda Souza Setti; Daniela Paes Almeida Ferreira Braga; Rita Cassia Savio Figueira; Assumpto Iaconelli; Edson Borges
Journal:  J Assist Reprod Genet       Date:  2012-10-06       Impact factor: 3.412

6.  Does morphological assessment predict oocyte developmental competence? A systematic review and proposed score.

Authors:  Alessandro Bartolacci; Giulia Intra; Giovanni Coticchio; Miriam dell'Aquila; Gilda Patria; Andrea Borini
Journal:  J Assist Reprod Genet       Date:  2022-01-07       Impact factor: 3.412

7.  GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology.

Authors:  Ana Marcia M Cota; Joao Batista A Oliveira; Claudia G Petersen; Ana L Mauri; Fabiana C Massaro; Liliane F I Silva; Andreia Nicoletti; Mario Cavagna; Ricardo L R Baruffi; José G Franco
Journal:  Reprod Biol Endocrinol       Date:  2012-04-27       Impact factor: 5.211

8.  Assessment of the relationship of basal serum anti-mullerian hormone levels with oocyte quality and pregnancy outcomes in patients undergoing ICSI.

Authors:  Gültekin Adanaş Aydın; Arzu Yavuz; Hasan Terzi; Tayfun Kutlu
Journal:  Iran J Reprod Med       Date:  2015-04

9.  Ca(2+) dynamics in oocytes from naturally-aged mice.

Authors:  Jenna Haverfield; Shoma Nakagawa; Daniel Love; Elina Tsichlaki; Michail Nomikos; F Anthony Lai; Karl Swann; Greg FitzHarris
Journal:  Sci Rep       Date:  2016-01-20       Impact factor: 4.379

10.  Oocyte Scoring Enhances Embryo-Scoring in Predicting Pregnancy Chances with IVF Where It Counts Most.

Authors:  Emanuela Lazzaroni-Tealdi; David H Barad; David F Albertini; Yao Yu; Vitaly A Kushnir; Helena Russell; Yan-Guang Wu; Norbert Gleicher
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.